Loading...
Loading...
INVO| Name | Value |
|---|---|
| Revenues | 1,757.1M |
| Cost of Revenue | 1,127.7M |
| Gross Profit | 629.3M |
| Operating Expense | 2,264.8M |
| Operating I/L | -1,635.5M |
| Other Income/Expense | -1,009.1M |
| Interest Income | 0.0M |
| Pretax | -2,644.6M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -2,644.6M |
INVO Bioscience, Inc. is a commercial-stage fertility company specializing in assisted reproductive technology solutions. Its flagship product, the INVOcell, is a medical device that facilitates fertilization and early embryo development within the woman's body. The company generates revenue by providing this innovative technology to fertility clinics and healthcare facilities worldwide.
